Details

Archived - Consultation on the Revised Guidance for Industry Preparation of the Quality Information for Drug Submissions in the CTD Format: Biotherapeutic and Blood Products - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T22:39:16.776Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/programs/consultation-revised-guidance-drug-submissions-ctd-biotherapeutic-blood-products.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-1/20250418223916/https://www.canada.ca/en/health-canada/programs/consultation-revised-guidance-drug-submissions-ctd-biotherapeutic-blood-products.html?wbdisable=false#ha_snapshot=249757
ID: 249757
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots